» Articles » PMID: 37862162

Association of Cytomegalovirus (CMV) DNAemia With Long-Term Mortality in a Randomized Trial of Preemptive Therapy and Antiviral Prophylaxis for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative Liver Transplant...

Overview
Journal Clin Infect Dis
Date 2023 Oct 20
PMID 37862162
Authors
Affiliations
Soon will be listed here.
Abstract

In a post-hoc analysis of the association of CMV DNAemia with long-term mortality in a randomized trial of CMV preemptive therapy vs. antiviral prophylaxis in D+R- liver transplant recipients, post-intervention CMV DNAemia was associated with increased mortality after adjusting for study arm.

Citing Articles

Antiviral Stewardship in Transplantation.

Bonda S, Trinh S, Hand J Viruses. 2025; 16(12.

PMID: 39772192 PMC: 11680139. DOI: 10.3390/v16121884.


Factors influencing intrapatient variability of tacrolimus and its association with 1-year post-transplant outcomes in pediatric liver transplant recipients.

Fang C, Dong C, Huang K, Wen N, Chen Y, Tang S Front Pharmacol. 2024; 15:1473891.

PMID: 39640481 PMC: 11617205. DOI: 10.3389/fphar.2024.1473891.


Prophylactic vs preemptive strategy for the prevention of CMV disease in solid organ transplant recipients: systematic review and meta-analysis of randomized controlled trials.

Reiss-Gindi N, Hoffman T, Ruderman T, Atamna A, Margalit I, Yahav D Infection. 2024; .

PMID: 39576569 DOI: 10.1007/s15010-024-02441-4.


Cytomegalovirus infection and cardiovascular outcomes in abdominal organ transplant recipients: A systematic review and meta-analysis.

Arvanitis P, Davis M, Farmakiotis D Transplant Rev (Orlando). 2024; 38(4):100860.

PMID: 38815340 PMC: 11586461. DOI: 10.1016/j.trre.2024.100860.


Recent advances in cytomegalovirus infection management in solid organ transplant recipients.

Grossi P, Peghin M Curr Opin Organ Transplant. 2024; 29(2):131-137.

PMID: 38288947 PMC: 10919264. DOI: 10.1097/MOT.0000000000001139.


References
1.
Spinner M, Saab G, Casabar E, Bowman L, Storch G, Brennan D . Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes. Transplantation. 2010; 90(4):412-8. PMC: 2924927. DOI: 10.1097/TP.0b013e3181e81afc. View

2.
Hunt P, Lee S, Siedner M . Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection. J Infect Dis. 2016; 214 Suppl 2:S44-50. PMC: 5021241. DOI: 10.1093/infdis/jiw275. View

3.
Pickering H, Sen S, Arakawa-Hoyt J, Ishiyama K, Sun Y, Parmar R . NK and CD8+ T cell phenotypes predict onset and control of CMV viremia after kidney transplant. JCI Insight. 2021; 6(21). PMC: 8663544. DOI: 10.1172/jci.insight.153175. View

4.
Singh N, Winston D, Razonable R, Lyon G, Silveira F, Wagener M . Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial. JAMA. 2020; 323(14):1378-1387. PMC: 7157180. DOI: 10.1001/jama.2020.3138. View

5.
Mumtaz K, Faisal N, Husain S, Morillo A, Renner E, Shah P . Universal prophylaxis or preemptive strategy for cytomegalovirus disease after liver transplantation: a systematic review and meta-analysis. Am J Transplant. 2014; 15(2):472-81. DOI: 10.1111/ajt.13044. View